FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lars Rosengren

Research Profile

Chemicals & Drugs

Concepts & Ideas

Anatomy

Procedures

Enzyme-Linked Immunosorbent Assay

Living Beings

Disorders

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Radu Constantinescu; Megan Romer; Lars Rosengren; Henrik Zetterberg; Karl Kieburtz
Increased levels of total tau protein in the cerebrospinal fluid in Huntington's disease.
R Constantinescu; O Corneliusson; B Holmberg; Bo Johnels; Lars Rosengren; Henrik Zetterberg
Light subunit of neurofilament triplet protein in the cerebrospinal fluid after subthalamic nucleus stimulation for Parkinson's disease.
M Axelsson; C Malmeström; Staffan Nilsson; Sara Haghighi; Lars Rosengren; J Lycke
Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lars Rosengren (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Radu Constantinescu; Megan Romer; Lars Rosengren; Henrik Zetterberg; Karl Kieburtz
Increased levels of total tau protein in the cerebrospinal fluid in Huntington's disease.
Parkinsonism & related disorders 2011;17(9):714-5.
2011: R Constantinescu; O Corneliusson; B Holmberg; Bo Johnels; Lars Rosengren; Henrik Zetterberg
Light subunit of neurofilament triplet protein in the cerebrospinal fluid after subthalamic nucleus stimulation for Parkinson's disease.
Acta neurologica Scandinavica 2011;124(3):206-10.
2011: M Axelsson; C Malmeström; Staffan Nilsson; Sara Haghighi; Lars Rosengren; J Lycke
Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis.
Journal of neurology 2011;258(5):882-8.
2011: Kaj Blennow; M Jonsson; Niels Andreasen; Lars Rosengren; Anders Wallin; P A Hellström; Henrik Zetterberg
No neurochemical evidence of brain injury after blast overpressure by repeated explosions or firing heavy weapons.
Acta neurologica Scandinavica 2011;123(4):245-51.
2011: Martin Gunnarsson; Clas Malmeström; Markus Axelsson; Peter Sundström; Charlotte Dahle; Magnus Vrethem; Tomas Olsson; Fredrik Piehl; Niklas Norgren; Lars Rosengren; Anders Svenningsson; Jan Lycke
Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.
Annals of neurology 2011;69(1):83-9.
2010: Radu Constantinescu; Ulf Andreasson; Susann Li; Vladimir N Podust; Niklas Mattsson; Rolf Anckarsäter; Henrik Anckarsäter; Lars Rosengren; Björn Holmberg; Kaj Blennow; Carsten Wikkelsö; Ulla Rüetschi; Henrik Zetterberg
Proteomic profiling of cerebrospinal fluid in parkinsonian disorders.
Parkinsonism & related disorders 2010;16(8):545-9.
2010: Michael Jonsson; Henrik Zetterberg; E van Straaten; Karin Lind; Steinar Syversen; Ake Edman; Kaj Blennow; Lars Rosengren; Leonardo Pantoni; D Inzitari; Anders Wallin
Cerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2010;17(3):377-82.
2010: Radu Constantinescu; Lars Rosengren; Bo Johnels; Henrik Zetterberg; Bjorn Holmberg
Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical Parkinsonian disorders.
Parkinsonism & related disorders 2010;16(2):142-5.
2010: Björn Fagerberg; Mikael Ryndel; Josefin Kjelldahl; Levent M Akyürek; Lars Rosengren; Lars Karlström; Göran Bergström; Fredrik J Olson
Differences in lesion severity and cellular composition between in vivo assessed upstream and downstream sides of human symptomatic carotid atherosclerotic plaques.
Journal of vascular research 2010;47(3):221-30.
2009: Marie Studahl; Göran Günther; Lars Rosengren
Serum S-100B protein levels in patients with herpes simplex encephalitis and tick-borne encephalitis--a marker of CNS damage during the initial stage of disease.
Journal of neurology 2009;256(4):586-90.
2009: N Mattsson; M Yaong; Lars Rosengren; Kaj Blennow; J-E Månsson; Oluf Andersen; Henrik Zetterberg; S Haghighi; I Zho; Domenico Pratico'
Elevated cerebrospinal fluid levels of prostaglandin E2 and 15-(S)-hydroxyeicosatetraenoic acid in multiple sclerosis.
Journal of internal medicine 2009;265(4):459-64.
2009: Radu Constantinescu; Megan Romer; David Oakes; Lars Rosengren; Karl Kieburtz
Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington's disease.
Parkinsonism & related disorders 2009;15(3):245-8.
2009: Radu Constantinescu; Henrik Zetterberg; Björn Holmberg; Lars Rosengren
Levels of brain related proteins in cerebrospinal fluid: an aid in the differential diagnosis of parkinsonian disorders.
Parkinsonism & related disorders 2009;15(3):205-12.
2008: Martin Ost; Karin Nylén; Ludwig Z Csajbok; Kaj Blennow; Lars Rosengren; Bengt Nellgård
Apolipoprotein E polymorphism and gender difference in outcome after severe traumatic brain injury.
Acta anaesthesiologica Scandinavica 2008;52(10):1364-9.
2008: Niklas Mattsson; Ulla Rüetschi; Yolande A L Pijnenburg; Marinus A Blankenstein; Vladimir N Podust; Susann Li; Inger Fagerberg; Lars Rosengren; Kaj Blennow; Henrik Zetterberg
Novel cerebrospinal fluid biomarkers of axonal degeneration in frontotemporal dementia.
Molecular medicine reports 2008;1(5):757-61.
2008: Gustaf Osterlundh; Ingemar Kjellmer; Birgitta Lannering; Lars Rosengren; Ulf A Nilsson; Ildikó Márky
Neurochemical markers of brain damage in cerebrospinal fluid during induction treatment of acute lymphoblastic leukemia in children.
Pediatric blood & cancer 2008;50(4):793-8.
2008: Karin Nylén; Martin Ost; Ludwig Z Csajbok; I Nilsson; C Hall; Kaj Blennow; Bengt Nellgård; Lars Rosengren
Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury.
Acta neurochirurgica 2008;150(3):221-7; discussion 227.
2007: Aina Agren-Wilsson; Annika Lekman; W Sjöberg; Lars Rosengren; Kaj Blennow; A Tommy Bergenheim; Jan Malm
CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus.
Acta neurologica Scandinavica 2007;116(5):333-9.
2007: Asa Mellgren; Richard W Price; Lars Hagberg; Lars Rosengren; Bruce J Brew; Magnus Gisslen
Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection.
Neurology 2007;69(15):1536-41.
2007: Pia Gudmundsson; Ingmar Skoog; Margda Waern; Kaj Blennow; Sigurdur Pálsson; Lars Rosengren; Deborah Gustafson
The relationship between cerebrospinal fluid biomarkers and depression in elderly women.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2007;15(10):832-8.
2007: Henrik Zetterberg; Michael Jonsson; Abdullah Rasulzada; Cornel Popa; Ewa Styrud; Max Albert Hietala; Lars Rosengren; Anders Wallin; Kaj Blennow
No neurochemical evidence for brain injury caused by heading in soccer.
British journal of sports medicine 2007;41(9):574-7.
2007: Sahra Abdulle; Asa Mellgren; Bruce J Brew; Paola Cinque; Lars Hagberg; Richard W Price; Lars Rosengren; Magnus Gisslen
CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration.
Journal of neurology 2007;254(8):1026-32.
2007: Magnus Gisslen; Lars Hagberg; Bruce J Brew; Paola Cinque; Richard W Price; Lars Rosengren
Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex.
The Journal of infectious diseases 2007;195(12):1774-8.
2007: Karin Nylén; Ludwig Z Csajbok; Martin Ost; Anas Rashid; Kaj Blennow; Bengt Nellgård; Lars Rosengren
Serum glial fibrillary acidic protein is related to focal brain injury and outcome after aneurysmal subarachnoid hemorrhage.
Stroke; a journal of cerebral circulation 2007;38(5):1489-94.
2007: Deborah R Gustafson; Ingmar Skoog; Lars Rosengren; Henrik Zetterberg; Kaj Blennow
Cerebrospinal fluid beta-amyloid 1-42 concentration may predict cognitive decline in older women.
Journal of neurology, neurosurgery, and psychiatry 2007;78(5):461-4.
2007: Niklas Mattsson; Sara Haghighi; Oluf Andersen; Yuemang Yao; Lars Rosengren; Kaj Blennow; Domenico Pratico'; Henrik Zetterberg
Elevated cerebrospinal fluid F2-isoprostane levels indicating oxidative stress in healthy siblings of multiple sclerosis patients.
Neuroscience letters 2007;414(3):233-6.
2007: Magnus Gisslen; Lars Hagberg; Lars Rosengren; Bruce J Brew; Paola Cinque; Serena S Spudich; Richard W Price
Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkers.
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 2007;2(1):112-9.
2006: Martin Ost; Karin Nylén; Ludwig Z Csajbok; A Olsson Ohrfelt; Mats Tullberg; Carsten Wikkelsö; P Nellgård; Lars Rosengren; Kaj Blennow; Bengt Nellgård
Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury.
Neurology 2006;67(9):1600-4.
2006: Henrik Zetterberg; Max Albert Hietala; Michael Jonsson; Niels Andreasen; Ewa Styrud; Ingvar Karlsson; Ake Edman; Cornel Popa; Abdullah Rasulzada; Lars-Olof Wahlund; Pankaj D Mehta; Lars Rosengren; Kaj Blennow; Anders Wallin
Neurochemical aftermath of amateur boxing.
Archives of neurology 2006;63(9):1277-80.
2006: Karin Nylén; Ludwig Z Csajbok; Martin Ost; A Rashid; Jan-Erik Karlsson; Kaj Blennow; Bengt Nellgård; Lars Rosengren
CSF -neurofilament correlates with outcome after aneurysmal subarachnoid hemorrhage.
Neuroscience letters 2006;404(1-2):132-6.
2006: Thorleif Thorlin; Jean-Michel Rouquette; Yngve Hamnerius; Elisabeth Hansson; Mikael Persson; Ulrika Björklund; Lars Rosengren; Lars Rönnbäck; Mikael Persson
Exposure of cultured astroglial and microglial brain cells to 900 MHz microwave radiation.
Radiation research 2006;166(2):409-21.
2006: Karin Nylén; Martin Ost; Ludwig Z Csajbok; I Nilsson; Kaj Blennow; Bengt Nellgård; Lars Rosengren
Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome.
Journal of the neurological sciences 2006;240(1-2):85-91.
2006: Lars-Magnus Andersson; Lars Hagberg; Lars Rosengren; Dietmar Fuchs; Kaj Blennow; Magnus Gisslen
Normalisation of cerebrospinal fluid biomarkers parallels improvement of neurological symptoms following HAART in HIV dementia--case report.
BMC infectious diseases 2006;6():141.
2006: Michelle M Mielke; Peter P Zandi; Kaj Blennow; Deborah Gustafson; Magnus Sjögren; Lars Rosengren; Ingmar Skoog
Low serum potassium in mid life associated with decreased cerebrospinal fluid Abeta42 in late life.
Alzheimer disease and associated disorders 2006;20(1):30-6.
2005: Magnus Gisslen; Lars Rosengren; Lars Hagberg; Steven G Deeks; Richard W Price
Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection.
AIDS research and therapy 2005;2():6.
2005: Annika Olsson; hugo vanderstichele; Niels Andreasen; Geert De Meyer; Anders Wallin; Björn Holmberg; Lars Rosengren; Eugeen Vanmechelen; Kaj Blennow
Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology.
Clinical chemistry 2005;51(2):336-45.
2005: Magnus Gisslen; Pam Fredman; Dietmar Fuchs; Annika Lekman; Lars Rosengren
Temporarily controlled HIV-1 replication after intravenous immunoglobulin treatment of Guillain-Barré syndrome.
Scandinavian journal of infectious diseases 2005;37(11-12):877-81.
2004: Niklas Norgren; P Sundström; A Svenningsson; Lars Rosengren; Torgny Stigbrand; Martin Gunnarsson
Neurofilament and glial fibrillary acidic protein in multiple sclerosis.
Neurology 2004;63(9):1586-90.
2004: Annika Olsson; Ludwig Z Csajbok; Martin Ost; Kina Höglund; Karin Nylén; Lars Rosengren; Bengt Nellgård; Kaj Blennow
Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury.
Journal of neurology 2004;251(7):870-6.
2004: Hans Rosén; Jan-Erik Karlsson; Lars Rosengren
CSF levels of neurofilament is a valuable predictor of long-term outcome after cardiac arrest.
Journal of the neurological sciences 2004;221(1-2):19-24.
2004: Sara Haghighi; Oluf Andersen; A Odén; Lars Rosengren
Cerebrospinal fluid markers in MS patients and their healthy siblings.
Acta neurologica Scandinavica 2004;109(2):97-9.
2003: Clas Malmeström; Sara Haghighi; Lars Rosengren; Oluf Andersen; Jan Lycke
Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS.
Neurology 2003;61(12):1720-5.
2003: Niklas Norgren; Lars Rosengren; Torgny Stigbrand
Elevated neurofilament levels in neurological diseases.
Brain research 2003;987(1):25-31.
2003: Estelle Trysberg; Karin Nylen; Lars Rosengren; Andrej Tarkowski
Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement.
Arthritis and rheumatism 2003;48(10):2881-7.
2003: Maria A I Aberg; Nils Aberg; Theo D Palmer; Ann-Marie Alborn; Christine Carlsson-Skwirut; Peter Bang; Lars Rosengren; Torsten Olsson; Fred H Gage; Peter S Eriksson
IGF-I has a direct proliferative effect in adult hippocampal progenitor cells.
Molecular and cellular neurosciences 2003;24(1):23-40.
2003: Lena Lindholm; Anders Bengtsson; Vigdis Hansdottir; Magnus Lundqvist; Lars Rosengren; Anders Jeppsson
Regional oxygenation and systemic inflammatory response during cardiopulmonary bypass: influence of temperature and blood flow variations.
Journal of cardiothoracic and vascular anesthesia 2003;17(2):182-7.
2003: Björn Holmberg; Bo Johnels; Kaj Blennow; Lars Rosengren
Cerebrospinal fluid Abeta42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy.
Movement disorders : official journal of the Movement Disorder Society 2003;18(2):186-90.
2002: Karin Nylén; Jan-Erik Karlsson; Christian Blomstrand; Andrej Tarkowski; Estelle Trysberg; Lars Rosengren
Cerebrospinal fluid neurofilament and glial fibrillary acidic protein in patients with cerebral vasculitis.
Journal of neuroscience research 2002;67(6):844-51.
2002: Niklas Norgren; Jan-Erik Karlsson; Lars Rosengren; Torgny Stigbrand
Monoclonal antibodies selective for low molecular weight neurofilaments.
Hybridoma and hybridomics 2002;21(1):53-9.
2002: Jarl Ahlberg; Christer Edlund; Carsten Wikkelsö; Lars Rosengren; Magnus Fall
Neurological signs are common in patients with urodynamically verified "idiopathic" bladder overactivity.
Neurourology and urodynamics 2002;21(1):65-70.
2001: Veerle Lejon; Dominique Legros; Lars Rosengren; Marc Gastellu-Etchegorry; Philippe Büscher
Biological data and clinical symptoms as predictors of astrogliosis and neurodegeneration in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.
The American journal of tropical medicine and hygiene 2001;65(6):931-5.
2001: Magnus Sjögren; M Blomberg; Michael Jonsson; Lars-Olof Wahlund; Ake Edman; Karin Lind; Lars Rosengren; Kaj Blennow; Anders Wallin
Neurofilament protein in cerebrospinal fluid: a marker of white matter changes.
Journal of neuroscience research 2001;66(3):510-6.
2001: Björn Holmberg; Bo Johnels; Pall E Ingvarsson; B Eriksson; Lars Rosengren
CSF-neurofilament and levodopa tests combined with discriminant analysis may contribute to the differential diagnosis of Parkinsonian syndromes.
Parkinsonism & related disorders 2001;8(1):23-31.
2001: Hans Rosén; Katharina Sunnerhagen; Johan Herlitz; Christian Blomstrand; Lars Rosengren
Serum levels of the brain-derived proteins S-100 and NSE predict long-term outcome after cardiac arrest.
Resuscitation 2001;49(2):183-91.
2001: Maria A I Aberg; Frida Ryttsén; G Hellgren; K Lindell; Lars Rosengren; A J MacLennan; Björn Carlsson; Owe Orwar; Peter S Eriksson
Selective introduction of antisense oligonucleotides into single adult CNS progenitor cells using electroporation demonstrates the requirement of STAT3 activation for CNTF-induced gliogenesis.
Molecular and cellular neurosciences 2001;17(3):426-43.
2000: Olof Zachrisson; Jan Balldin; R Ekman; Ole Naesh; Lars Rosengren; Hans Agren; Kaj Blennow
No evident neuronal damage after electroconvulsive therapy.
Psychiatry research 2000;96(2):157-65.
2000: Nils Aberg; Björn Carlsson; Lars Rosengren; Jan Oscarsson; Olle G P Isaksson; Lars Rönnbäck; Peter S Eriksson
Growth hormone increases connexin-43 expression in the cerebral cortex and hypothalamus.
Endocrinology 2000;141(10):3879-86.
2000: Sara Haghighi; Oluf Andersen; Lars Rosengren; T Bergström; J Wahlström; S Nilsson
Incidence of CSF abnormalities in siblings of multiple sclerosis patients and unrelated controls.
Journal of neurology 2000;247(8):616-22.
2000: Mats Tullberg; Jan-Eric Månsson; Pam Fredman; Annika Lekman; Kaj Blennow; R Ekman; Lars Rosengren; Magnus Tisell; Carsten Wikkelsø
CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy.
Journal of neurology, neurosurgery, and psychiatry 2000;69(1):74-81.
2000: Magnus Sjögren; Lars Rosengren; Lennart Minthon; Pia Davidsson; Kaj Blennow; Anders Wallin
Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD.
Neurology 2000;54(10):1960-4.
2000: Elisabeth Tarkowski; A Ringqvist; Lars Rosengren; Christer Jensen; Sven Ekholm; Ake Wennmalm
Intrathecal release of nitric oxide and its relation to final brain damage in patients with stroke.
Cerebrovascular diseases (Basel, Switzerland) 2000;10(3):200-6.
2000: Lars Hagberg; Dietmar Fuchs; Lars Rosengren; Magnus Gisslen
Intrathecal immune activation is associated with cerebrospinal fluid markers of neuronal destruction in AIDS patients.
Journal of neuroimmunology 2000;102(1):51-5.
1999: Anders Wallin; Kaj Blennow; Lars Rosengren
Cerebrospinal fluid markers of pathogenetic processes in vascular dementia, with special reference to the subcortical subtype.
Alzheimer disease and associated disorders 1999;13 Suppl 3():S102-5.
1999: Lars Rosengren; Jan-Erik Karlsson; Magnus Sjögren; Kaj Blennow; Anders Wallin
Neurofilament protein levels in CSF are increased in dementia.
Neurology 1999;52(5):1090-3.
1999: Leif Dotevall; Lars Hagberg; Jan-Erik Karlsson; Lars Rosengren
Astroglial and neuronal proteins in cerebrospinal fluid as markers of CNS involvement in Lyme neuroborreliosis.
European journal of neurology : the official journal of the European Federation of Neurological Societies 1999;6(2):169-78.
1999: Elisabeth Tarkowski; Lars Rosengren; Christian Blomstrand; Christer Jensen; Sven Ekholm; Andrej Tarkowski
Intrathecal expression of proteins regulating apoptosis in acute stroke.
Stroke; a journal of cerebral circulation 1999;30(2):321-7.
1999: Veerle Lejon; Lars Rosengren; Philippe Büscher; Jan-Erik Karlsson; H N Sema
Detection of light subunit neurofilament and glial fibrillary acidic protein in cerebrospinal fluid of Trypanosoma brucei gambiense-infected patients.
The American journal of tropical medicine and hygiene 1999;60(1):94-8.
1998: Lars-Magnus Andersson; Pam Fredman; Annika Lekman; Lars Rosengren; Magnus Gisslen
Increased cerebrospinal fluid ganglioside GD3 concentrations as a marker of microglial activation in HIV type 1 infection.
AIDS research and human retroviruses 1998;14(12):1065-9.
1998: Mats Tullberg; Lars Rosengren; Elisabeth Blomsterwall; Jan-Erik Karlsson; Carsten Wikkelsö
CSF neurofilament and glial fibrillary acidic protein in normal pressure hydrocephalus.
Neurology 1998;50(4):1122-7.
1998: Jan Lycke; Jan-Erik Karlsson; Oluf Andersen; Lars Rosengren
Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 1998;64(3):402-4.
1998: Hans Rosén; Lars Rosengren; Johan Herlitz; Christian Blomstrand
Increased serum levels of the S-100 protein are associated with hypoxic brain damage after cardiac arrest.
Stroke; a journal of cerebral circulation 1998;29(2):473-7.
1998: Björn Holmberg; Lars Rosengren; Jan-Erik Karlsson; Bo Johnels
Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1998;13(1):70-7.
1997: Elisabeth Tarkowski; Lars Rosengren; Christian Blomstrand; Carsten Wikkelsö; Christer Jensen; Sven Ekholm; Andrej Tarkowski
Intrathecal release of pro- and anti-inflammatory cytokines during stroke.
Clinical and experimental immunology 1997;110(3):492-9.
1996: Lars Rosengren; Jan-Erik Karlsson; J O Karlsson; L I Persson; C Wikkelsø
Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF.
Journal of neurochemistry 1996;67(5):2013-8.
1996: Anders Wallin; Kaj Blennow; Lars Rosengren
Glial fibrillary acidic protein in the cerebrospinal fluid of patients with dementia.
Dementia (Basel, Switzerland) 1996;7(5):267-72.
1996: Leif Dotevall; Lars Rosengren; Lars Hagberg
Increased cerebrospinal fluid levels of glial fibrillary acidic protein (GFAp) in Lyme neuroborreliosis.
Infection 1996;24(2):125-9.
1995: Lars Rosengren; J Lycke; Oluf Andersen
Glial fibrillary acidic protein in CSF of multiple sclerosis patients: relation to neurological deficit.
Journal of the neurological sciences 1995;133(1-2):61-5.
1995: Elisabeth Tarkowski; Lars Rosengren; Christian Blomstrand; Carsten Wikkelsö; Christer Jensen; Sven Ekholm; Andrej Tarkowski
Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke.
Stroke; a journal of cerebral circulation 1995;26(8):1393-8.
1994: Lars Rosengren; C Wikkelsø; Lars Hagberg
A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults.
Journal of neuroscience methods 1994;51(2):197-204.
1993: G Ahlsén; Lars Rosengren; M Belfrage; A Palm; Kenneth G Haglid; Anders Hamberger; Christopher Gillberg
Glial fibrillary acidic protein in the cerebrospinal fluid of children with autism and other neuropsychiatric disorders.
Biological psychiatry 1993;33(10):734-43.
1993: Jan-Erik Karlsson; Lars Rosengren; S Wang; Nils Danielsen; Kenneth G Haglid
Glial and neuronal marker proteins in the silicone chamber model for nerve regeneration.
Journal of neurochemistry 1993;60(3):1098-104.
1993: Jan-Erik Karlsson; S Wang; Lars Rosengren; Kenneth G Haglid
Quantitative alterations of S-100 protein and neuron specific enolase in the rat nervous system after chronic 2,5-hexanedione exposure.
Neurochemical research 1993;18(2):203-8.
1992: S Wang; G J Lees; Lars Rosengren; Jan-Erik Karlsson; Anders Hamberger; Kenneth G Haglid
Proteolysis of filament proteins in glial and neuronal cells after in vivo stimulation of hippocampal NMDA receptors.
Neurochemical research 1992;17(10):1005-9.
1992: Lars Rosengren; G Ahlsén; M Belfrage; Christopher Gillberg; Kenneth G Haglid; Anders Hamberger
A sensitive ELISA for glial fibrillary acidic protein: application in CSF of children.
Journal of neuroscience methods 1992;44(2-3):113-9.
1991: A Aurell; Lars Rosengren; B Karlsson; J E Olsson; V Zbornikova; Kenneth G Haglid
Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction.
Stroke; a journal of cerebral circulation 1991;22(10):1254-8.
1991: Jan-Erik Karlsson; Lars Rosengren; Kenneth G Haglid
Quantitative and qualitative alterations of neuronal and glial intermediate filaments in rat nervous system after exposure to 2,5-hexanedione.
Journal of neurochemistry 1991;57(4):1437-44.
1991: S Wang; G J Lees; Lars Rosengren; Jan-Erik Karlsson; stigbrand torgny; Anders Hamberger; Kenneth G Haglid
The effect of an N-methyl-D-aspartate lesion in the hippocampus on glial and neuronal marker proteins.
Brain research 1991;541(2):334-41.
1990: Lars Barregård; Carsten Wikkelsö; Lars Rosengren; A Aurell; G Thiringer; L Nilson; Gerd Sällsten; Kenneth G Haglid; Christian Blomstrand
Cerebrospinal fluid proteins in men with chronic encephalopathy after exposure to organic solvents.
Scandinavian journal of work, environment & health 1990;16(6):423-7.
1990: S Wang; Lars Rosengren; Jan-Erik Karlsson; stigbrand torgny; Kenneth G Haglid
A simple quantitative dot-immunobinding assay for glial and neuronal marker proteins in SDS-solubilized brain tissue extracts.
Journal of neuroscience methods 1990;33(2-3):219-27.
1989: Jan-Erik Karlsson; Lars Rosengren; Kenneth G Haglid
Polyclonal antisera to the individual neurofilament triplet proteins: a characterization using ELISA and immunoblotting.
Journal of neurochemistry 1989;53(3):759-65.
1989: Lars Rosengren; Kenneth G Haglid
Long term neurotoxicity of styrene. A quantitative study of glial fibrillary acidic protein (GFA) and S-100.
British journal of industrial medicine 1989;46(5):316-20.
1989: A Aurell; Lars Rosengren; C Wikkelsø; G Nordberg; Kenneth G Haglid
The S-100 protein in cerebrospinal fluid: a simple ELISA method.
Journal of the neurological sciences 1989;89(2-3):157-64.
1988: A McRae-Degueurce; Lars Rosengren; Kenneth G Haglid; I Augustsson; Annica Dahlström
Dopaminergic terminals in the rat locus coeruleus: an immunocytochemical investigation.
Acta physiologica Scandinavica 1988;133(4):583-5.
1988: A McRae-Degueurce; Lars Rosengren; Kenneth G Haglid; S Bööj; Carl-Gerhard Gottfries; A C Granérus; Annica Dahlström
Immunocytochemical investigations on the presence of neuron-specific antibodies in the CSF of Parkinson's disease cases.
Neurochemical research 1988;13(7):679-84.
1987: Jan-Erik Karlsson; Lars Rosengren; Kenneth G Haglid
A rapid HPLC method to separate the triplet proteins of neurofilament.
Journal of neurochemistry 1987;49(5):1375-8.
1987: Jan-Erik Karlsson; Lars Rosengren; Per Kjellstrand; Kenneth G Haglid
Effects of low-dose inhalation of three chlorinated aliphatic organic solvents on deoxyribonucleic acid in gerbil brain.
Scandinavian journal of work, environment & health 1987;13(5):453-8.
1987: Lars Rönnbäck; Peter S Eriksson; J Zeuchner; Lars Rosengren; A Wronski
Aspects of abstinence after morphine ingestion.
Pharmacology, biochemistry, and behavior 1987;28(1):87-93.
1986: C Briving; Anders Hamberger; Per Kjellstrand; Lars Rosengren; Jan-Erik Karlsson; Kenneth G Haglid
Chronic effects of dichloromethane on amino acids, glutathione and phosphoethanolamine in gerbil brain.
Scandinavian journal of work, environment & health 1986;12(3):216-20.
1986: Lars Rosengren; Per Kjellstrand; A Aurell; Kenneth G Haglid
Irreversible effects of dichloromethane on the brain after long term exposure: a quantitative study of DNA and the glial cell marker proteins S-100 and GFA.
British journal of industrial medicine 1986;43(5):291-9.
1986: Lars Rönnbäck; E Hansson; Aroldo Cupello; Maria Vittoria Rapallino; J Zeuchner; Lars Rosengren
Neurotransmitter uptake in various brain regions of chronically morphinized rats.
Neurochemical research 1986;11(2):317-26.
1986: Lars Rosengren; Per Kjellstrand; A Aurell; Kenneth G Haglid
Irreversible effects of xylene on the brain after long term exposure: a quantitative study of DNA and the glial cell marker proteins S-100 and GFA.
Neurotoxicology 1986;7(3):121-35.
1986: O Nilsson; Annica Dahlström; S Bööj; Lars Rosengren; K Haglid; jacques Baudier; D Gérard
Immunocytochemical localisation of caligulin-like immunoreactivity in rat tissues.
Medical biology 1986;64(2-3):103-8.
1986: C Briving; I Jacobson; Anders Hamberger; Per Kjellstrand; Kenneth G Haglid; Lars Rosengren
Chronic effects of perchloroethylene and trichloroethylene on the gerbil brain amino acids and glutathione.
Neurotoxicology 1986;7(1):101-8.
1985: Lars Rosengren; A Aurell; Per Kjellstrand; Kenneth G Haglid
Astrogliosis in the cerebral cortex of gerbils after long-term exposure to 1,1,1-trichloroethane.
Scandinavian journal of work, environment & health 1985;11(6):447-55.
1985: Lars Rosengren; A Wronski; C Briving; Kenneth G Haglid
Long lasting changes in gerbil brain after chronic ethanol exposure: a quantitative study of the glial cell marker S-100 and DNA.
Alcoholism, clinical and experimental research 1985;9(2):109-13.
1985: O D Laerum; Sverre Mork; A Haugen; E Bock; Lars Rosengren; K Haglid
Differentiation markers (S-100, GFAP, NSE and D2) in fetal rat brain cells during malignant transformation in cell culture.
Journal of neuro-oncology 1985;3(2):137-46.
1984: Lars-Gunnar Kindblom; Pär Lodding; Lars Rosengren; jacques Baudier; K Haglid
S-100 protein in melanocytic tumors. An immunohistochemical investigation of benign and malignant melanocytic tumors and metastases of malignant melanoma and a characterization of the antigen in comparison to human brain.
Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology 1984;92(4):219-30.
1984: Ola Nilsson; Annica Dahlström; K O Grönstad; Lars Rosengren; C Briving; G Skolnik; Håkan Ahlman
Successful transplantation of a human midgut carcinoid tumour to the anterior eye chamber of the rat.
Acta physiologica Scandinavica 1984;120(2):317-9.
1984: Lars Rönnbäck; J Zeuchner; Lars Rosengren; A Wronski; S O Ogren
Decreased morphine intake by opiate addicted rats administered zimelidine, a 5-HT uptake inhibitor.
Psychopharmacology 1984;82(1-2):30-5.
1983: H Björklund; D Dahl; K Haglid; Lars Rosengren; L Olson
Astrocytic development in fetal parietal cortex grafted to cerebral and cerebellar cortex of immature rats.
Brain research 1983;285(2):171-80.
1982: J Zeuchner; Lars Rosengren; A Wronski; Lars Rönnbäck
A new ingestion method for long-term morphine intoxication in rat.
Pharmacology, biochemistry, and behavior 1982;17(3):495-501.
1982: L I Persson; Lars Rosengren
Kinetics of blood-brain barrier dysfunction to albumin around small cerebral stab wounds.
Acta neurologica Scandinavica 1982;65(1):1-5.
1981: Kenneth G Haglid; C Briving; H A Hansson; Lars Rosengren; P Kjellstrand; D Stavron; U Swedin; A Wronski
Trichloroethylene: long-lasting changes in the brain after rehabilitation.
Neurotoxicology 1981;2(4):659-73.
1980: L I Persson; Lars Rosengren; B B Johansson
Albumin extravasation in bicuculline-induced blood-brain barrier dysfunction. A comparison between endogeneous and 125I-labeled exogeneous serum albumin.
Acta neurologica Scandinavica 1980;62(4):259-62.
1980: Kenneth G Haglid; Per Kjellstrand; Lars Rosengren; A Wroński; C Briving
Effects of trichloroethylene inhalation on proteins of the gerbil brain.
Archives of toxicology 1980;43(3):187-99.